University of Copenhagen: Covid-19 vaccine candidate based on UCPH-research ready for testing on humans

A few days from now the first human will be vaccinated with a Danish vaccine candidate against COVID-19. It is developed by a team of researchers at the University of Copenhagen in collaboration with the companies AdaptVac, ExpreS2ion Biotechnologies and Bavarian Nordic. The vaccine candidate, ABNCoV2, has just been approved for human clinical testing. So far, the research data look promising.

’Our vaccine candidate is characterised in that it elicits a strong immune response in animals. We hope and believe that the strong immune response both results in effective and long-lasting protection’, says Professor Ali Salanti.

Read More